Role of pancreatic trypsin in chronic esophagitis induced by gastroduodenal reflux in rats

Journal of Gastroenterology

Volumn 41, Issue 3, 2006, Pages 198-208

  Naito, Yuji ^a   Uchiyama, Kazuhiko ^b   Kuroda, Masaaki ^b   Takagi, Tomohisa ^a   Kokura, Satoshi ^a   Yoshida, Norimasa ^b   Ichikawa, Hiroshi ^c   Yoshikawa, Toshikazu ^a,b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY   (Japan)

Author keywords

Camostat mesilate; Esophagitis; Pancreatic protease; Trypsin

Indexed keywords

ALPHA CHEMOKINE; CXCL1 PROTEIN, RAT; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; TRYPSIN; TRYPSIN INHIBITOR; TRYPSIN, PANCREATIC, TYPE V S; TRYPSIN, PANCREATIC, TYPE V-S;

ANIMAL; ARTICLE; BIOSYNTHESIS; CHRONIC DISEASE; COMPARATIVE STUDY; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; DUODENOGASTRIC REFLUX; ENZYMOLOGY; ESOPHAGITIS; INTESTINE MUCOSA; MALE; METABOLISM; PATHOLOGY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WISTAR RAT;

ANIMALS; CHEMOKINES, CXC; CHRONIC DISEASE; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; DISEASE MODELS, ANIMAL; DUODENOGASTRIC REFLUX; ESOPHAGITIS; INTESTINAL MUCOSA; MALE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, WISTAR; RECEPTOR, PAR-1; RECEPTOR, PAR-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRYPSIN; TRYPSIN INHIBITORS;

EID: 33947411516     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-005-1742-5     Document Type: Article

References (45)

1. Chiba N. Proton pump inhibitors in acute healing and maintenance of erosive or worse esophagitis: a systematic overview. Can J Gastroenterol 1997;11 Suppl B:66B-73B.
2. Robinson M, Lanza F, Avner D, Haber M. Effective maintenance treatment of reflux esophagitis with low-dose lansoprazole. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1996;124:859-67.
3. Escourrou J, Deprez P, Saggioro A, Geldof H, Fischer R, Maier C. Maintenance therapy with pantoprazole 20mg prevents relapse of reflux oesophagitis. Aliment Pharmacol Ther 1999;13: 1481-91.
4. Fitzgerald R, Onwuegbusi B, Bajaj-Elliott M, Saeed I. Diversity in the oesophageal phenotypic response to gastrooesophageal reflux: immunological determinants. Gut 2002;50: 451-9.
5. Isomoto H, Wang A, Mizuta Y, Akazawa Y. Elevated levels of chemokines in esophageal mucosa of patients with reflux esophagitis. Am J Gastroenterol 2003;98:551-6.
6. Yoshida N, Uchiyama K, Kuroda M, Sakuma K, Kokura S, Ichikawa H, et al. Interleukin-8 expression in the esophageal mucosa of patients with gastroesophageal reflux disease. Scand J Gastroenterol 2004;39:816-22.
7. Kauer WK, Peters JH, DeMeester TR, Ireland AP, Bremner CG, Hagen JA. Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg 1995;222:525-31; discussion 31-3.
8. Gillen P, Keeling P, Byrne PJ, Healy M, O'Moore RR, Hennessy TP. Implication of duodenogastric reflux in the pathogenesis of Barrett's oesophagus. Br J Surg 1988;75:540-3.
9. Mud HJ, Kranendonk SE, Obertop H, Van Houten H, Westbroek DL. Active trypsin and reflux oesophagitis: an experimental study in rats. Br J Surg 1982;69:269-72.
10. Salo JA, Kivilaakso E. Contribution of trypsin and cholate to the pathogenesis of experimental alkaline reflux esophagitis. Scand J Gastroenterol 1984;19:875-81.
11. Johnson LF, Harmon JW. Experimental esophagitis in a rabbit model. Clinical relevance. J Clin Gastroenterol 1986;8 Suppl 1:26- 44.
12. Asokananthan N, Graham PT, Fink J, Knight DA, Bakker AJ, McWilliam AS, et al. Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells. J Immunol 2002;168:3577-85.
13. Kawabe A, Shimada Y, Soma T, Maeda M, Itami A, Kaganoi J, et al. Production of prostaglandin E2 via bile acid is enhanced by trypsin and acid in normal human esophageal epithelial cells. Life Sci 2004;75:21-34.
14. Tamura Y, Hirado M, Okamura K, Minato Y, Fujii S. Synthetic inhibitors of trypsin, plasmin, kallikrein, thrombin, C1r-, and C1 esterase. Biochim Biophys Acta 1977;484:417-22.
15. Imada T, Chen C, Hatori S, Shiozawa M, Rino Y. Effect of trypsin inhibitor on reflux oesophagitis after total gastrectomy in rats. Eur J Surg 1999;165:1045-50.
16. Sasaki I. Effect of camostat in the treatment of reflux esophagitis after gastrectomy: an experimental study in rats and a pilot clinical study. Biomed Res 1989;10:167-73.
17. Oh TY, Lee JS, Ahn BO, Cho H, Kim WB, Kim YB, et al. Oxidative damages are critical in pathogenesis of reflux esophagitis: implication of antioxidants in its treatment. Free Radic Biol Med 2001;30:905-15.
18. Oh TY, Lee JS, Ahn BO, Cho H, Kim WB, Kim YB, et al. Oxidative stress is more important than acid in the pathogenesis of reflux oesophagitis in rats. Gut 2001;49:364-71.
19. Ismail-Beigi F, Horton PF, Pope CE 2nd. Histological consequences of gastroesophageal reflux in man. Gastroenterology 1970;58:163-74.
20. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
21. Kawabata S, Miura T, Morita T, Kato H, Fujikawa K, Iwanaga S, et al. Highly sensitive peptide-4-methylcoumaryl-7-amide substrates for blood-clotting proteases and trypsin. Eur J Biochem 1988;172:17-25.
22. Zhang F, Altorki NK, Wu YC, Soslow RA, Subbaramaiah K, Dannenberg AJ. Duodenal reflux induces cyclooxygenase-2 in the esophageal mucosa of rats: evidence for involvement of bile acids. Gastroenterology 2001;121:1391-9.
23. Kawai T, Ikeda H, Harada Y, Saitou T. Changes in the rat stomach after long-term administration of proton pump inhibitors (AG-1749 and E-3810). Nippon Rinsho 1992;50:188-93.
24. Lin TM, Evans DC, Warrick MW, Pioch RP. Actions of nizatidine, a selective histamine H2-receptor antagonist, on gastric acid secretion in dogs, rats and frogs. J Pharmacol Exp Ther 1986;239:406-10.
25. Ito Y, Nakamura S, Onoda Y, Sugawara Y, Takaiti O. Effects of the new anti-ulcer drug ecabet sodium (TA-2711) on pepsin activity. I. Inactivation of enzyme protein. Jpn J Pharmacol 1993;62: 169-74.
26. Hamaguchi M, Fujiwara Y, Takashima T, Hayakawa T, Sasaki E, Shiba M, et al. Increased expression of cytokines and adhesion molecules in rat chronic esophagitis. Digestion 2003;68:189- 97.
27. Omura N, Kashiwagi H, Chen G, Yano F, Suzuki Y, Aoki T. Effects of ecabet sodium on experimentally induced reflux esophagitis. J Gastroenterol 2000;35:504-9.
28. Bohm SK, Khitin LM, Grady EF, Aponte G, Payan DG, Bunnett NW. Mechanisms of desensitization and resensitization of proteinase-activated receptor-2. J Biol Chem 1996;271:22003-16.
29. Cenac N, Coelho AM, Nguyen C, Compton S, Andrade-Gordon P, MacNaughton WK, et al. Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. Am J Pathol 2002;161:1903-15.
30. Nguyen TD, Moody MW, Steinhoff M, Okolo C, Koh DS, Bunnett NW. Trypsin activates pancreatic duct epithelial cell ion channels through proteinase-activated receptor-2. J Clin Invest 1999;103:261-9.
31. Olejar T, Matej R, Zadinova M, Pouckova P. Expression of proteinase- activated receptor 2 during taurocholate-induced acute pancreatic lesion development in Wistar rats. Int J Gastrointest Cancer 2001;30:113-21.
32. Yoshida N, Katada K, Kuroda M, Shimozawa M, Uchiyama K, Naito Y, et al. Trypsin activates human esophageal epithelial cells to produce inflammatory cytokines through protease-activated receptor 2. Gastroenterology 2004;126:A-501.
33. Watanabe K, Iida M, Takaishi K, Suzuki T, Hamada Y, Iizuka Y, et al. Chemoattractants for neutrophils in lipopolysaccharideinduced inflammatory exudate from rats are not interleukin-8 counterparts but gro-gene-product/ melanoma-growth-stimulatingactivity- related factors. Eur J Biochem 1993;214:267-70.
34. Suzuki H, Suematsu M, Miura S, Liu YY, Watanabe K, Miyasaka M, et al. Rat CINC/gro: a novel mediator for locomotive and secretagogue activation of neutrophils in vivo. J Leukoc Biol 1994;55:652-7.
35. Imamoto E, Yoshida N, Uchiyama K, Higashihara H, Tomatsuri N, Ueda M, et al. Effects of bile acids and acidic exposure on IL- 8 expression in human esophageal epithelial cells. Gastroenterology 2003;124:A-409.
36. Naito Y, Yoshikawa T. Molecular and cellular mechanisms involved in Helicobacter pylori-induced inflammation and oxidative stress. Free Radic Biol Med 2002;33:323-36.
37. Wilson KT, Fu S, Ramanujam KS, Meltzer SJ. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res 1998;58:2929-34.
38. Thun MJ. NSAIDs and esophageal cancer: ready for trials but not yet broad clinical application. Gastroenterology 2003;124:246-8.
39. Kaur BS, Khamnehei N, Iravani M, Namburu SS, Lin O, Triadafilopoulos G. Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barrett's esophagus. Gastroenterology 2002;123:60-7.
40. Houliston RA, Keogh RJ, Sugden D, Dudhia J, Carter TD, Wheeler-Jones CP. Protease-activated receptors upregulate cyclooxygenase-2 expression in human endothelial cells. Thromb Haemost 2002;88:321-8.
41. Frungieri MB, Weidinger S, Meineke V, Kohn FM, Mayerhofer A. Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPARgamma: possible relevance to human fibrotic disorders. Proc Natl Acad Sci U S A 2002;99:15072-7.
42. Yada K, Shibata K, Matsumoto T, Ohta M, Yokoyama S, Kitano S. Protease-activated receptor-2 regulates cell proliferation and enhances cyclooxygenase-2 mRNA expression in human pancreatic cancer cells. J Surg Oncol 2005;89:79-85.
43. Nehra D, Howell P, Williams CP, Pye JK, Beynon J. Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity. Gut 1999;44:598-602.
44. Gotley DC, Morgan AP, Ball D, Owen RW, Cooper MJ. Composition of gastro-oesophageal refluxate. Gut 1991;32:1093-9.
45. Salmo JA, Lehto VP, Myllarniemi HS, Kivilaakso EO. Morphological alterations in tryptic esophagitis: an experimental light microscopic and scanning and transmission electron microscopic study in rabbits. J Surg Res 1990;49:14-7.